-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Company Profile
Pharmstandard – Company Profile
Pharmstandard develops, manufactures and distributes a range of pharmaceutical products. The company offers prescription pharmaceuticals and over-the (OTC) drugs. It also provides contract manufacturing services. Pharmstandard’s product portfolio includes drugs for treatments of cardio-vascular diseases, gastroenterology diseases, cancer, neurology diseases, diabetes, contagious diseases, growth hormone deficiency, metabolic disorders and other diseases. The company serves customers in the Commonwealth of Independent States and Former Soviet Union countries. Pharmstandard is headquartered in Dolgoprudny, Moscow, Russia.
Add to Basket -
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Sector Analysis
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...
-
Product Insights
Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016" provides an overview of Severe Acute Respiratory Syndrome (SARS) clinical trials scenario. This report provides top line data relating to the clinical trials on Severe Acute Respiratory Syndrome (SARS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...